features. In GCA, the vascular inflammation may affect a series of arteries, such as the vertebral, coronary and mesenteric arteries, most often the external carotid branches, particularly the superior temporal artery, in addition to the aorta and its branches. 1) The clinical manifestations of aortitis/arteritis are usually vague and nonspecific constitutional presentations, such as pain, fever, malaise, myalgia, and weight loss, etc. 2) Laboratory examinations may reveal significantly elevated erythrocyte sedimentation rate and C-reactive protein with leukocytosis and elevated neutrophils. 2) Aortitis can be a common cause of fever of unknown origin (FUO), particularly in the patients with the use of a tumor necrosis factor-α inhibitor (represented by infliximab (Remicade)) 3) or with sepsis. 4) The incidence of this entity is difficult to assess, and it is often associated with diagnostic dilemma and unnecessary work-ups due to its nonspecific manifestations. 1) The present article is to discuss the diagnostic concerns of aortitis in the presence of FUO.
Ann Thorac Cardiovasc Surg 2018; 24: 279-287 Online August 29, 2018 doi: 10.5761/atcs.ra. Pereira et al. 5) noted ethnic differences of incidences of GCA, with a 20 times lower incidence in Asians than in Caucasians. Patients with GCA typically present with constitutional symptoms, such as headache, jaw claudication, fever, weight loss, myalgia, arthralgia, or malaise. 6) Pamuk et al. 7) compared GCA and polymyalgia rheumatica in terms of constitutional symptoms including fever, and noted a significant higher prevalence in the nonspecific constitutional symptoms in GCA than in polymyalgia rheumatica group (78.9% vs. 49 .1%, p = 0.024). In 2014, Jokar and Mirfeizi 8) reported 30 cases of GCA from Iran, from which they noted that fever (20%) was the second most common manifestation of GCA next to headache (96.7%). One of their patients presented with FUO, accounting for 3.3% of the whole group and 16.7% of febrile patients. By comparison, the prevalence of fever was 56.2% in India, 55.4% in Japan, and 42% in Caucasian, respectively. Zabala López et al. 9) reported a 78-year-old patient with GCA presented with 5-week FUO before the diagnosis was made with a sign of weakening temporal pulse. His thoracoabdominal computed tomography (CT) showed a thickened abdominal aortic wall, and the diagnosis was made by biopsy of the temporal artery. Temporal artery biopsy is the gold standard for diagnosis of GCA, which reveals diffuse infiltration of the inflammatory cells in the arterial walls, sometimes with giant cells and disruption of the elastic lamina (Fig. 1) . Pereira et al. 5) reported the positivities of temporal artery biopsies were 81.6% in Caucasians, 2.6% in Asians, and 15.8% in others. Pamuk et al. 7) reported 19 GCA patients, 13 (68.4%) of which had pertinent pathological changes of GCA in biopsies of the temporal arteries, and the giant cells were positive in 5 (26.3%) patients. Schäfer et al. 10) described a 79-year-old woman with FUO but negative temporal artery biopsies in whom diagnosis of GCA was therefore delayed. Further CT angiogram and positron emission tomography (PET)-CT scan revealed diffuse extensive active vasculitis. 11) Schattner and Klepfish 12) reported three patients with prolonged fever were diagnosed as chronic aortic dissection, GCA, and TA, respectively. The authors stated that GCA often presented with FUO, but rarely with left pleural effusions, whereas in TA patients, the pleural effusions were probably resulted from aortitis and pulmonary artery involvement.
Takayasu arteritis
TA, also known as pulseless disease, is a chronic inflammatory arteritis, affecting large vessels, predominately in the aorta and its main branches. Although TA is a panarteritis, the initial site of inflammation is around the vasa vasorum and at the medioadventitial junction. TA is characterized by arterial stenosis; however, aneurysmal formation can also be seen in such patients. In the acute phase, patients may present with weakness, fever, arthralgias, myalgias, weight loss, and pleuritic pain. 13) Laboratory findings may include anemia (44%) and elevated erythrocyte sedimentation rate (78%). 14) TA can cause FUO, and is difficult to diagnose and make the patient subjected to multiple unnecessary studies and hospitalizations. The febrile course in an extreme TA patient was as long up to 10 months. 14) However, TA patients rarely presented with FUO. 15) Hall et al. 16 ) reported 4 of their 32 TA patients had FUO with an incidence of 12.5% of the patient setting. In some patients with FUO, the diagnosis of TA was established only after bruits and pulselessness were present. [17] [18] [19] Differential diagnosis from rheumatic heart disease is recommended when TA patient present with FUO associated with mitral valve regurgitation. 20) By CT angiography, Tavora et al. 13) found that 95% (81/85) TA patients had aortic involvement with or without affecting the aortic branches, and 5% (4/85) patients had only aortic branch involvement. As in CT angiography, magnetic resonance angiography may show arterial stenoses at multiple levels, mural thrombi, thickening of aortic valve cusps, and pericardial effusions. 1) Sueyoshi et al. 21) reported, of 31 patients with TA, aortic aneurysms were found in 45.2% (14/31), 52.9% (9/17) aneurysms increased in size, and 33.3% (3/9) enlarged aneurysms increased in size rapidly and ruptured during the follow-up period. In a retrospective review, Liang et al. 22) described on 64 patients with aortic aneurysm resection due to noninfectious aortitis. Histologically, giant cells were seen in 71.9%.
The characteristic histological changes of TA are a multifocal lymphoplasmacytic infiltrate around vasa vasorum of the adventitia with extension into the media, sometimes with presence of giant cells and endarteritis obliterans. 13) Imaging techniques including magnetic resonance imaging (MRI), CT, gallium-67 scintigraphy, and ultrasonography that may show circular, hypoechogenic arterial wall thickening are helpful for early diagnosis of TA presenting with FUO. 15) Recently, PET-CT is highly praised for its unique diagnostic values for TA and other rheumatological aortitis by an enhanced uptake value (SUV max ) of 18 F-fluorodeoxyglucose (FDG) in the aortic walls. 23) It is also a promising method for the assessment of disease activity. 24) A patient with a 2-month FUO, arthralgia and elevated erythrocyte sedimentation rate was diagnosed with TA by PET-CT, which showed enhanced uptake in the affected aorta. 25) Moreover, among serum cytokines, tumor necrosis factor-α might be more sensitive than interleukins and matrix metalloproteinases for the purpose of differential diagnosis of TA. 23) Pathologically, the acute phase of TA has not been sufficiently elucidated, but reports documented thickening of the wall based on radiographic investigations, instead. The pathological characteristics of late phase of TA are adventitial fibrosis, medial necrosis, and scarring with chronic inflammation and fibrous intimal thickening, constituting a tree-bark gross appearance, similar to the changes of syphilitic aortitis. 13) There are edema and mononuclear cell infiltration in the media and adventitia as well as giant cell granulomatous reactions and laminar necrosis. 26) 
Infective aortitis
Infective aortitis is uncommon, with an incidence of 0.3%-0.4% based on autopsic series, 27) but it can be lethal. Infective aortitis most often affects the thoracic and abdominal aorta. 28) The underlying microorganisms associated with infectious aortitis were most often Staphylococcus, Enterococcus, Streptococcus, and Salmonella species. 28) Aortitis due to Mycobacterium tuberculosis or Campylobacter fetus have been reported. 28) Infective endocarditis and urinary or gastrointestinal infections might be a source of bacteriemia responsible for the etiology of infective aortitis. 29) Symptoms vary and are usually fever, pains, and a palpable aneurysm. 30) A 48-year-old man with bacterial aortitis presenting with a 9-day fever and chills, developed into infective mycotic aneurysm. Excised aortic tissue revealed methicillin-resistant Staphylococcus aureus and Enterococcus faecium. 31) Of them, fever was the most common symptom of patients with infective aortitis. 32) FUO can be a major symptom of infective aortitis. 27) Leukocytosis and neutrophilia are seen in patients. Erythrocyte sedimentation rate and C-reactive protein will also be elevated. Pentraxin-3 (PTX3), a product of protective response to inflammation, is another promising potential biomarker for infective endocarditis, 28) vasculitis, GCA, and TA. 33) PTX3 might be produced within the vascular wall of inflammatory infiltrates by the endothelial cells or macrophages, and a correlation between plasma PTX3 level and TA activity was found. 33) PTX3 is a feature of vascular inflammation in GCA, and it was observed that GCA patients with a disease course of <6 months showed a significant higher PTX3 level. 34) In infective aortitis, CT showed focal wall thickening, fluid attenuation, and inflammation changes. 28) CT angiogram may show periaortic inflammation, aortic aneurysms, or progressive aortic dilation. Other CT findings include periaortic soft-tissue masses and fluid collections. 27 ) Early stages of aortitis show irregular enhancement of the aortic wall on CT imaging, consistent with mural and early periaortic inflammation. 31) In syphilitic aortitis, for example, pathological examinations may reveal medial destruction with inflammation, zonal necrosis, and a polymorphic infiltrate of mononuclear inflammatory cells. 13) In a patient with syphilitic aortitis, ascending aortic aneurysm was formed, and the resected aortic tissues inspected histologically showed multiple inflammatory cell infiltration in the affected aortic wall (Fig. 2) .
The overall mortality of patients with infectious aortitis was reported to be 21%-44%. 32) Medical treatment alone carries a high mortality, whereas the mortality with surgery combined with antimicrobial treatment is lower. Antimicrobial treatments include cephalosporins, fluoroquinolones, and anti-staphylococcal antibiotics. Surgical therapy (extra-anatomic and in situ bypass grafts) and endovascular stent grafts have been used in those with ruptured or leaking thoracic aneurysms and in a limited number of patients. 32) Ankylosing spondylitis, Cogan syndrome, and relapsing polychondritis
Ankylosing spondylitis often has mild constitutional symptoms. Fever in such patient is absent or slight, but sometimes can be high. 35) The fever was once attributed to the presence of Klebsiella infection and human leukocyte antigen B27. 35) The diagnosis of ankylosing spondylitis is based on radiography and (or) laboratory tests of C-reactive protein or human leukocyte antigen B27. 36) The pathology of the aortitis due to ankylosing spondylitis is characterized by local medial elastic destruction, intimal thickening, and endarteritis obliterans of the adventitia, similar to luetic aortitis. 37) Cogan syndrome is a chronic autoimmune disease with an unknown etiology, typically presents with interstitial keratitis and auditory and (or) vestibular dysfunction. The clinical manifestations of Cogan syndrome are often nonspecific, varying among fever, arthralgias, arthritis, cutaneous exanthema, and urticaria, etc. It is occasionally associated with systemic vasculitis and aortitis. Some patients with Cogan syndrome may manifest as a febrile syndrome and thus it makes the diagnosis difficult. Decreased visual and auditory acuity can be helpful for the diagnosis. 38) PET/CT may reveal the changes of diffuse aortitis. 39) Prednisone treatment can lead to a progressive improvement and disappearance of fever. 38) Relapsing polychondritis is a rare immune and inflammatory disorder affecting the cartilage. It can be associated with aortic involvement and present with fever during the disease progression. PET/CT can show a diffuse FDG accumulation in the local site of inflammation. Pathologically, the aortic wall can be infiltrated with lymphocytes and macrophages, and fibrinoid necrosis can be noted. Relapsing polychondritis with severe aortitis has been successfully treated with tocilizumab. 40) 
Differential Diagnosis
In the differential diagnosis of aortitis presenting with FUO, rheumatic diseases including adult Still's disease, polymyalgia rheumatica, late onset rheumatoid arthritis, systemic lupus erythematosus, polyarteritis nodosa, and Kikuchi's disease that cause prolonged fever and erythrocyte sedimentation >100 mm/hour should be considered. 14) Rheumatologic serologies, complements (C3, C4, and CH50), cryoglobulins, antineutrophil cytoplasmic antibody (ANCA), skin biopsy, temporal artery biopsy, and medical imaging can be helpful for the differential diagnosis.
There are many similarities between GCA and TA, and they are even considered as different phenotypes of one disease. 41) They affect predominantly female patients and white race, and are likely to relapse after successful treatment. 41) Nevertheless, in patients with TA, 97% of the arterial lesions are stenotic, 3% are aneurysmal and 8% of patients are both stenoses and aneurysms. On the contrary, in patients with GCA, 75% of arterial lesions are stenotic, 62% are aneurysmal involvements of the aorta, and 41% are both stenoses and aneurysms. However, there are no significant differences in regard to fever between the two diseases. In GCA, aneurysmal formation may occur 6-7 years after the diagnosis is made. 9) Castañer et al. 42) found that patients with GCA were 17.3 times more likely to develop a thoracic aortic aneurysm and 2.4 times more likely to develop an abdominal aortic aneurysm in comparison to the general population. Patients with GCA or isolated aortitis had significantly larger proximal descending aortas than TA (GCA: 33.9 ± 8.12 mm; isolated aortitis: 38.1 ± 28.9 mm; TA: 21.1 ± 1.8 mm; p = 0.0012) and thoracoabdominal aortas (p = 0.048) at discharge. 43) Shu et al. 31) presented the incidence of aortic dissection in GCA (8%, 4/50) and TA (0%, 0/8). However, the incidences of aortic dissection in GCA and TA patients presenting with fever and FUO were unknown. Yuan 44) published a systematic review presenting the clinical features of 51 patients with aortic dissection and FUO as a primary symptom, and only one patient was due to GCA. In patients with aortitis, echocardiography is recommended to determine the associated infective endocarditis and assess valve function under the condition of aortic dilation. In patients with FUO, duplex ultrasonography, MRI of the aortic arch, biopsy of the temporal artery, and FDG-PET were preferred diagnostic means. 45) The diagnostic value of MRI was noticeable due to its high sensitivity and specificity in etiological diagnosis of FUO. 45) FDG-PET/CT is praised for its sensitivity and its extreme values in the differential diagnosis of inflammations of patients presenting with FUO, including TA, GCA, and immunoglobulin G4-related disease. 46) It can provide functional information for disease activity, staging, biopsy guidance, and monitoring response to treatment. 2) In patients with FUO with suspected focal infection or inflammation, FDG-PET with intense uptake seems to be a valuable diagnostic evidence of aortitis; however, for early aortitis cases, MRI and PET diagnoses may be discordant. 47) FDG-PET has been proved superior to gallium-67 scintigraphy in patients with FUO. 48) Aortitis often manifests fever, usually with prolonged and low-grade fever; however, patients with relapsing polychondritis can have spiking fever, and those with infective aortitis can have high fever. A comparison of symptom, fever style, affected lesion, imaging and histological characteristics comparing GCA, TA, infective and other types of arteritis are shown in Table 1 .
Management
Management of noninfective aortitis consists of immunosuppression with high-dose corticosteroid therapy. Surgery and percutaneous intervention are best avoided due to the early complications associated with aortic wall fragility, prosthetic valve dehiscence, and refractory inflammation. In patients with GCA presenting with aortic valve incompetence and ascending aortic aneurysm extending to the proximal arch, the patients often warrant total arch replacement and aortic valve replacement or valvoplasty. Endovascular stent grafts with less trauma and diminished organ injury complications in the repair of infectious aortitis, in particular for mycotic aneurysms, have been successful recently. 3) A 6-week to lifelong suppressive oral antibiotics is recommended. 3) Patients with infective aortitis usually present with nonspecific symptoms and many were FUO. Diagnostic work-ups could be angiography, CT angiography, and Doppler ultrasonography. FDG-PET may show abnormally increased FDG uptake in the affected aorta and aortic branches. Treatment of choice includes high-dose steroids and steroid-sparing drugs. In patients with infective aortitis, who presented with fever, leukocytosis, back pain, and abdominal mass, the most commonly identified organisms could be Salmonella and Staphylococcus. The surgical techniques include excision with in situ repair, extra-anatomic bypass, and primary lateral closure. Lopes et al. 49) proposed that infected aorta excision with in situ or extra-anatomic graft placement is a golden standard of infective aortitis. Endovascular aortic repair is an alternative treatment of infected aortic aneurysms and has obtained promising results. Patients with combined surgical and conservative treatments are associated with a good survival rate of 75%-100% prior to aneurysmal formation, and a survival rate of 62% after aneurysmal formation. The surgical mortality rate can be up to 65% in cases of ruptured aortic aneurysm, and the mortality rate can be as high as 90% if the patients are treated conservatively only. The application of endovascular aortic repair has led to a significantly decreased postoperative mortality to 10.4%. A meta-analysis on endovascular management of mycotic aorta aneurysms by Kan et al. 50) showed that the 30-day and 2-year survival rates were 89.6% ± 4.4% and 82.2% ± 5.8%, respectively, and perioperative fever could be a significant predictor of infection. Under such circumstances, patients with infected aortic aneurysms were still with increased mortality and morbidity rates irrespective of aggressive treatments, such as extensive resection and debridement, in situ or extra-anatomical graft insertion and broad-spectrum antibiotics.
Conclusion
The inflammatory changes in aortitis, even the lesion was occult could be a cause of FUO. The development of the aortitis may predispose into fatal conditions like aortic aneurysms or dissections, thus prompt diagnosis and further treatment are crucial for promoting the patients' prognosis. FDG-PET/CT is helpful for the differential diagnosis of aortitis presenting with FUO.
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